Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant

PK/PD Pseudomonas aeruginosa ceftazidime/avibactam continuous infusion hollow fiber multidrug-resistant

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
22 Oct 2022
Historique:
received: 28 09 2022
revised: 20 10 2022
accepted: 20 10 2022
entrez: 11 11 2022
pubmed: 12 11 2022
medline: 12 11 2022
Statut: epublish

Résumé

This study correlates in vivo findings in a patient with an extensively drug-resistant (XDR)

Identifiants

pubmed: 36358110
pii: antibiotics11111456
doi: 10.3390/antibiotics11111456
pmc: PMC9686790
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI17/00251
Organisme : La Marató TV3
ID : 138/U/2018

Références

Can J Hosp Pharm. 2017 Mar-Apr;70(2):156-160
pubmed: 28487584
Antimicrob Agents Chemother. 2014 Jun;58(6):3091-9
pubmed: 24637685
J Chromatogr Sci. 2016 Jul;54(6):1037-40
pubmed: 27048639
Clin Infect Dis. 2021 Nov 2;73(9):1664-1676
pubmed: 33618353
J Antimicrob Chemother. 2015;70(6):1650-8
pubmed: 25645206
J Glob Antimicrob Resist. 2021 Sep;26:15-19
pubmed: 33989847
Antimicrob Agents Chemother. 2005 Apr;49(4):1306-11
pubmed: 15793102
Clin Infect Dis. 2003 Sep 15;37(6):745-51
pubmed: 12955633
Clin Microbiol Infect. 2021 Nov;27(11):1631-1637
pubmed: 34015532
Clin Infect Dis. 2003 Apr 15;36(8):1006-12
pubmed: 12684913
Microb Drug Resist. 2021 Mar;27(3):342-349
pubmed: 32762605
J Antimicrob Chemother. 2017 Apr 1;72(4):1109-1117
pubmed: 28077672
Adv Drug Deliv Rev. 2014 Nov 20;77:3-11
pubmed: 25038549
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29483119
J Antimicrob Chemother. 2015 Dec;70(12):3178-83
pubmed: 26188037
Eur J Drug Metab Pharmacokinet. 2018 Apr;43(2):155-170
pubmed: 29027128
Int J Antimicrob Agents. 2019 Mar;53(3):234-245
pubmed: 30472292
Microbiol Spectr. 2022 Jun 29;10(3):e0089222
pubmed: 35695526
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29530842
J Antimicrob Chemother. 2018 Mar 1;73(3):564-568
pubmed: 29216348
Semin Respir Crit Care Med. 2017 Jun;38(3):264-270
pubmed: 28578551
Open Forum Infect Dis. 2019 Sep 28;6(10):ofz416
pubmed: 31660373
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30082283
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Microbiol Spectr. 2021 Sep 3;9(1):e0058521
pubmed: 34319141
J Antimicrob Chemother. 2018 Mar 1;73(3):658-663
pubmed: 29149337
J Clin Pharmacol. 2020 Feb;60(2):172-180
pubmed: 31423601
Antimicrob Agents Chemother. 2020 Mar 24;64(4):
pubmed: 32041712
Sci Rep. 2021 Nov 12;11(1):22178
pubmed: 34773066
J Antimicrob Chemother. 2015 Oct;70(10):2862-9
pubmed: 26133566

Auteurs

Inmaculada Lopez-Montesinos (I)

Infectious Diseases Service, Hospital del Mar, 08003 Barcelona, Spain.
Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain.
Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, 08002 Barcelona, Spain.

María Milagro Montero (MM)

Infectious Diseases Service, Hospital del Mar, 08003 Barcelona, Spain.
Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, 08002 Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.

Sandra Domene-Ochoa (S)

Infectious Diseases Service, Hospital del Mar, 08003 Barcelona, Spain.
Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
Department of Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain.
Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, 08002 Barcelona, Spain.

Carla López-Causapé (C)

CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.
Servicio de Microbiología y Unidad de Investigación, Hospital Son Espases, IdISBa, 07120 Palma de Mallorca, Spain.

Daniel Echeverria (D)

Pharmacy Service, Hospital del Mar, 08003 Barcelona, Spain.

Luisa Sorlí (L)

Infectious Diseases Service, Hospital del Mar, 08003 Barcelona, Spain.
Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, 08002 Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.

Nuria Campillo (N)

Pharmacy Service, Hospital del Mar, 08003 Barcelona, Spain.

Sonia Luque (S)

Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.
Pharmacy Service, Hospital del Mar, 08003 Barcelona, Spain.

Eduardo Padilla (E)

Microbiology Service, Laboratori de Referència de Catalunya, 08820 Barcelona, Spain.

Nuria Prim (N)

Microbiology Service, Laboratori de Referència de Catalunya, 08820 Barcelona, Spain.

Santiago Grau (S)

Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.
Pharmacy Service, Hospital del Mar, 08003 Barcelona, Spain.

Antonio Oliver (A)

CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.
Servicio de Microbiología y Unidad de Investigación, Hospital Son Espases, IdISBa, 07120 Palma de Mallorca, Spain.

Juan P Horcajada (JP)

Infectious Diseases Service, Hospital del Mar, 08003 Barcelona, Spain.
Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, 08002 Barcelona, Spain.
CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.

Classifications MeSH